SCHEMBL9843320

SCHEMBL9843320

CCc1cc2c(cc1C#Cc1ccc(C(=O)O)c(CC)n1)C(C)(C)CC(C)(C)O2

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GABRP O00591 1/20 0.36
GABRD O14764 1/20 0.36
GABRA1 P14867 1/20 0.36
GABRB1 P18505 1/20 0.36
GABRG2 P18507 1/20 0.36
GABRB3 P28472 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36
GABRA4 P48169 1/20 0.36
GABRE P78334 1/20 0.36
GABRA6 Q16445 1/20 0.36
GABRG1 Q8N1C3 1/20 0.36
GABRG3 Q99928 1/20 0.36
GABRQ Q9UN88 1/20 0.36
AKR1B1 P15121 4/20 0.33
SSTR5 P35346 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8890799 0.91 GABRP (0.36) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9334964 0.85 GABRP (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8875315 0.79 AKR1B1 (0.35) AKR1B1
SCHEMBL8874982 0.78 CYP26A1 (0.40) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9526910 0.76 RARB (0.37) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL9318429 0.76 RXRA (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8865958 0.76 RARA (0.51)
SCHEMBL9850176 0.75 RXRA (0.43) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL8875640 0.75 AKR1B1 (0.35) AKR1B1
SCHEMBL8865678 0.74 AKR1B1 (0.31) AKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0419130-A2 Acetylenes disubstituted with a heteroaromatic group and A 2-substituted chromanyl, thiochromanyl or 1,2,3,4- tetrahydroquinolinyl group having retinoid-like activity ALLERGAN, INC. (US) 1991-03-27 EP disclosed